SCHEMBL17208335

SCHEMBL17208335

O=C1C(c2ccccc2)=C(N2CCCCC2)C(=O)N1c1ccc(Cl)c(Cl)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAD51 Q06609 7/20 0.64
▸ BCL2A1 Q16548 7/20 0.60
▸ RAD1 O60671 2/20 0.58
▸ ALDH1A1 P00352 3/20 0.54
▸ L3MBTL1 Q9Y468 3/20 0.54
▸ HPGD P15428 2/20 0.54
▸ ALOX15 P16050 2/20 0.54
▸ HSD17B10 Q99714 2/20 0.54
▸ MAPT P10636 2/20 0.54
▸ TSHR P16473 1/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ LMNA P02545 1/20 0.52
▸ BCL2 P10415 1/20 0.52
▸ ALOX12 P18054 1/20 0.52
▸ BID P55957 1/20 0.52
▸ BCL2L1 Q07817 1/20 0.52
▸ BCL2L2 Q92843 1/20 0.52
▸ MEN1 O00255 1/20 0.48
▸ POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15758183 0.88 RAD51 (0.74) RAD51BCL2A1RAD1ALDH1A1ALOX15
SCHEMBL5682657 0.84 L3MBTL1 (0.66) RAD51BCL2A1ALDH1A1L3MBTL1HPGD
SCHEMBL13912138 0.81 BCL2A1 (0.75) RAD51BCL2A1RAD1ALDH1A1L3MBTL1
SCHEMBL13912151 0.80 BCL2A1 (0.77) RAD51BCL2A1RAD1ALDH1A1L3MBTL1
SCHEMBL17201930 0.78 RAD51 (1.00) RAD51BCL2A1RAD1ALDH1A1MAPT
SCHEMBL17208336 0.76 RAD51 (0.78) RAD51BCL2A1RAD1ALDH1A1L3MBTL1
SCHEMBL17202955 0.76 RAD51 (0.75) RAD51BCL2A1RAD1ALDH1A1L3MBTL1
SCHEMBL15757929 0.76 RAD51 (0.74) RAD51BCL2A1RAD1ALDH1A1MAPT
SCHEMBL15758221 0.75 RAD51 (0.72) RAD51BCL2A1RAD1ALDH1A1ALOX15
SCHEMBL17201949 0.74 RAD51 (0.74) RAD51BCL2A1RAD1ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150306069-A1 METHODS AND COMPOSITIONS INVOLVING RAD51 INHIBITORS THE UNIVERSITY OF CHICAGO (US) 2015-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150306069-A1 METHODS AND COMPOSITIONS INVOLVING RAD51 INHIBITORS RAD51, MRE11, RAD50 RAD51 1/4885BCL2A1 951/4885RAD1 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback